Update of safety information for medicinal products containing dabrafenib; trametinib, adopted by the PRAC committee during the review of signals discussed at the meeting on January 6-9, 2023
31.03.2023
845
In accordance with paragraph 8 of Section IV of the Procedure for conducting expert evaluation, the applicant must amend the instruction for medical use of the medicinal product…
Read more
